4,300 Shares in Semler Scientific, Inc. (NASDAQ:SMLR) Purchased by Douglass Winthrop Advisors LLC

Douglass Winthrop Advisors LLC purchased a new stake in Semler Scientific, Inc. (NASDAQ:SMLR) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 4,300 shares of the company’s stock, valued at approximately $232,000.

Several other institutional investors have also recently made changes to their positions in SMLR. Principal Financial Group Inc. bought a new position in shares of Semler Scientific in the third quarter valued at $361,000. Verition Fund Management LLC bought a new position in shares of Semler Scientific in the 3rd quarter valued at about $251,000. Geode Capital Management LLC increased its stake in shares of Semler Scientific by 10.5% during the 3rd quarter. Geode Capital Management LLC now owns 135,959 shares of the company’s stock worth $3,202,000 after purchasing an additional 12,964 shares during the last quarter. IFP Advisors Inc bought a new stake in shares of Semler Scientific in the 4th quarter valued at about $54,000. Finally, Cerity Partners LLC lifted its stake in Semler Scientific by 91.5% in the 3rd quarter. Cerity Partners LLC now owns 1,345,586 shares of the company’s stock valued at $31,689,000 after purchasing an additional 642,982 shares during the last quarter. Institutional investors and hedge funds own 49.37% of the company’s stock.

Analyst Ratings Changes

Separately, Lake Street Capital boosted their price target on Semler Scientific from $40.00 to $71.00 and gave the stock a “buy” rating in a research report on Friday, January 24th.

Semler Scientific Price Performance

Shares of Semler Scientific stock opened at $39.22 on Friday. The business has a fifty day simple moving average of $47.23 and a two-hundred day simple moving average of $44.07. Semler Scientific, Inc. has a 1 year low of $20.88 and a 1 year high of $81.56. The company has a market capitalization of $376.39 million, a price-to-earnings ratio of 7.99 and a beta of 1.33.

Semler Scientific (NASDAQ:SMLR) last posted its earnings results on Tuesday, February 18th. The company reported $3.41 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.20 by $3.21. The company had revenue of $12.41 million during the quarter. Semler Scientific had a net margin of 72.65% and a return on equity of 50.77%.

Semler Scientific Profile

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.